A population study showing that the advent of second generation tyrosine kinase inhibitors has improved progression-free survival in chronic myeloid leukaemia-Reference-Cited by-同舟云学术

A population study showing that the advent of second generation tyrosine kinase inhibitors has improved progression-free survival in chronic myeloid leukaemia

Published:2013-07 Issue:7 Volume:37 Page:752-758
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Francis Sebastian,Lucas Claire,Lane Steven,Wang Lihui,Watmough Sarah,Knight Katy,Bell Jo,Kaleel-Rahman Mohammed,Lee Edwin,O’Brien David,Butt Nauman M.,Sadik Walid,De Soysa Lally,Seale Jim R.C.,Salim Rahuman,Clark Richard E.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference11 articles.

1. CD81 Is Essential for HSC Self-Renewal through Suppressing Proliferation

2. Imatinib for newly diagnosed patients with chronic myeloid leukemia: incidence of sustained responses in an intention-to-treat analysis;de Lavallade;J Clin Oncol,2008

3. Dasatinib in imatinib-resistant Philadelphia chromosome-positive leukemias;Talpaz;N Engl J Med,2006

4. Nilotinib is effective in patients with chronic myeloid leukemia in chronic phase after imatinib resistance or intolerance: 24-month follow-up results;Kantarjian;Blood,2011

5. Dasatinib-associated major molecular responses in patients with chronic myeloid leukemia in chronic phase following imatinib failure: response dynamics and predictive value;Hochhaus;Leukemia,2009

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clear Improvement in Real-World Chronic Myeloid Leukemia Survival: A Comparison With Randomized Controlled Trials;Frontiers in Oncology;2022-07-14

2. Influence of genetic polymorphisms in glutathione-S-transferases gene in response to imatinib among Brazilian patients with chronic myeloid leukemia;Molecular Biology Reports;2021-03

3. Glutathione S‐transferase gene polymorphic sequence variations: Association with risk and response to Imatinib among Chronic Myeloid Leukemia patients of Kashmir;International Journal of Laboratory Hematology;2021-01-20

4. Influence of glutathione S‐transferases (GSTM1, GSTT1, and GSTP1) genetic polymorphisms and smoking on susceptibility risk of chronic myeloid leukemia and treatment response;Molecular Genetics & Genomic Medicine;2019-05-20

5. GSTM1 and GSTP1 , but not GSTT1 genetic polymorphisms are associated with chronic myeloid leukemia risk and treatment response;Cancer Epidemiology;2016-10